About Ketryx | Company Information - Ketryx
About Ketryx
We’re building the future of regulated AI
Ketryx helps high-performing teams move at the speed of AI, without compromising on compliance. Built by and for engineers in medtech, our platform brings safety and velocity together in one seamless system.
Trusted By:
.png) .png)
Built for scale. Proven in the field.
"With Ketryx, we automated and streamlined far more than expected. Work that would have taken us a year was completed in just 90 days because of their expertise, partnership, and platform. Had we chosen another provider, our confidence and our timeline would have looked very different."
Tsimafei Savitski, Chief Legal and Compliance Officer, Flo Health
0 of 5
Top medtech firms
0M+
Patient lives improved
0x
Faster development
0%
Reduction in documentation time
Strategic capital from across the industry
From Fortune 500 to high-growth innovators, companies building life-saving products rely on Ketryx to scale fast, and prove compliance at every step.
Investor Spotlight
Guru Chahal Partner
Bill Hawkins Former Chairman and CEO
Vinay Shah Partner & Founding Member
"Ketryx is uniquely positioned to help companies around the world develop software faster while remaining safe and compliant." Guru Chahal Partner, Lightspeed
Lorem ipsum
Michal Preminger
Former Head of Innovation, Massbio
“I love what Erez and team have built. I wish it was available when I was running Medtronic.” Bill Hawkins Former Chairman and CEO, Medtronic
"Fortune 500 giants and fast-growing innovators consistently praise Ketryx for proving that compliance can accelerate progress." Vinay Shah Partner & Founding Member, Transformation Capital
Our Mission
Make regulated systems safe and reliable through technology.
Our Vision
A world where products perform without unintended harm.
Who we serve
Teams building the most critical products in the world, who can’t afford to get it wrong.
Founded by builders who lived it
From research project to industry platform
2021
2022
2023
2024
2025
2026
Founding Ketryx
While leading AI and ML initiatives at Amgen, Erez Kaminski hit a persistent blocker: Quality and Regulatory teams required high assurance and documentation, but existing tools couldn't keep up. In 2021, Erez co-founded Ketryx with Jan Pöschko from Wolfram Research. Their vision: use AI and deterministic systems to make regulated software development as seamless as modern unregulated workflows, because software teams shouldn't have to choose between velocity and validation. That year, they brought on FDA regulatory veteran Paul Jones and began building the first integrations for Jira and GitHub.
2022
First Customers, First Proof Points
With seed funding from MIT's E14 Fund and Ubiquity Ventures, the team got to work building the core platform: a central orchestration layer that could connect tools like Jira and GitHub into a single, traceable software development lifecycle. That year, Ketryx signed its first customers, proving that regulated teams no longer had to choose between modern dev workflows and compliance.
2023
Series A and Scaling
Ketryx closed a $14M Series A led by Lightspeed Venture Partners, with continued backing from E14 Fund and Ubiquity Ventures. The funding fueled a push to scale the product and commercial engine as demand from regulated software teams (especially those building AI-powered medical devices) began to outpace the founding team's capacity. By year's end, the company had raised over $18M.
2024
Product-Market Fit, Enterprise Growth
Ketryx signed leading MedTech manufacturers and began working with three of the world's top five medical device companies. Products built on Ketryx accounted for 2-3% of all FDA AI/ML software approvals, and the platform's reach grew to impact over 20 million patients. The team shipped its best in-class AI-powered technology including requirement creation, suggested traceability links, and auto-generated release notes, along with FDA-ready SBOM generation and new integrations. Key hires rounded out a leadership bench built for scale. Ketryx also renewed its UL Certifications and heightened compliance standards.
2025
Series B and the Future of Safe AI
Ketryx launched the industry's first validated AI Agents for regulated industries, reducing manual compliance work by 90% while keeping humans in the loop for safety-critical decisions. In September, Ketryx raised a $39M Series B led by Transformation Capital. Former Medtronic CEO Bill Hawkins joined as an investor, alongside continued support from Lightspeed, E14 Fund, Ubiquity Ventures, and 53 Stations. Total funding crossed $55M, and the company accelerated global expansion, growing teams in Boston and Vienna.
2026
Regulated AI at Scale
Ketryx entered 2026 with its strongest momentum to date. Four of the top five Fortune 500 MedTech companies now run on the platform, and Ketryx-powered products reach more than 100 million patients worldwide. As demand for validated AI surges across life sciences, Ketryx is proving that safety-critical product development no longer has to be slow, and that AI-assisted compliance infrastructure for regulated products is a competitive necessity.
An Extension of Your Team
Our People Make the Difference
Every engagement is backed by our team of Quality leaders and life science experts. From initial discovery to full-scale deployment, we’re an extension of your team.
Erez Kaminski
CEO & Founder
Passionate about advancing patient care through AI and software, with experience spanning Amgen, Wolfram Research, and MIT.
Read full bio
Previously:
Erez Kaminski
CEO & Founder](/content/about/company#/index.html)
Jan Pöschko
CTO & Founder
Jan is a veteran software and infrastructure leader who co-built Wolfram|Alpha and led Wolfram Cloud development for over a decade.
Read full bio
Previously:
Jan Pöschko
CTO & Founder](/content/about/company#/index.html)
Mary Brook Delano
Chief Business Officer
Mary Brook is a commercial leader with a track record of scaling teams and driving $100M+ growth in life sciences.
Read full bio
Previously:
Mary Brook Delano
Chief Business Officer](/content/about/company#/index.html)
Brian Katzman
Chief Marketing Officer
Brian is a veteran marketing leader who helped launch Tile and has spent two decades driving growth across leading tech and MedTech companies.
Read full bio
Previously:
Brian Katzman
Chief Marketing Officer](/content/about/company#/index.html)
Tim Brodeur
VP, Success & Delivery
Tim is a life sciences software leader who built success teams at Veeva, Benchling, and Causaly.
Read full bio
Previously:
Tim Brodeur
VP, Success & Delivery](/content/about/company#/index.html)
Paul Jones
VP, Regulatory Strategy
A globally recognized software safety expert, Paul shaped the FDA’s medical software standards and advances safe, compliant development across life sciences.
Read full bio
Previously:
Paul Jones
VP, Regulatory Strategy](/content/about/company#/index.html)
Randall Markham
VP, Operations & Finance
Randall is an operations leader with experience driving performance across industrial, defense, and technology organizations.
Read full bio
Previously:
Randall Markham
VP, Operations & Finance](/content/about/company#/index.html)
How we show up every day
A culture that reaches to build it right the first time
We take our mission seriously, but not ourselves. Our culture blends transparency, discipline, and momentum, because you can’t build safety at scale without all three. Sound like your kind of team?
Our Values
Move On What Matters
Take the first step. We move fast on what matters most—prioritizing action, momentum, and meaningful outcomes over unnecessary tinkering. We don’t chase perfect; we always deliver, iterate, and learn.
Give Autonomy. Own It.
Leaders create goals, clarity, and context. From that, we push decisions, ownership and accountability to the people closest to the problem. They own them and follow-through without prompting.
Scale Quality to Consequence
We take a risk-based approach; apply the highest standards where they matter most. In patient-impacting systems, we pursue excellence. For internal work, speed and iteration are often the right trade-off.
Continuously Learn
We believe in continuous improvement. We get better every day—individually and as a company. This is about constant feedback loops, candid and caring conversations, iteration, self-reflection, and experimentation.
Chase Problems Together
We take on meaningful, ambitious challenges—side by side. We move as a team, lift each other up, and celebrate shared wins before scaling the next peak.
Do What Compounds
We invest in the things that grow in value over time—skills, systems, people, relationships, and habits. We prioritize our enduring advantage, and we build with tomorrow in mind.
In the News
The industry is paying attention
Our approach to AI, safety, and compliance has been featured in Boston Business Journal, R&D World, and more.
Medical device leaders share AI hot takes at The MedTech Conference
MedTech Dive
• October 27, 2026
Read more
4 questions about the FDA’s approach to generative AI
MedTech Dive
• September 9, 2026
Read more
Former Medtronic CEO Joins Ketryx Board
Medical Product Outsourcing
• June 25, 2026
Read more
Ex-Medtronic CEO Bill Hawkins joins Ketryx board
Medical Design & Outsourcing
• June 25, 2026
Read more
Erez Kaminski, Co-Founder & CEO at Ketryx on serving 100M+ customers and scaling regulated products
MGMT Boston - The Lantern
• April 7, 2026
Read more
Watch how Ketryx applies AI to automate compliance in regulated software
CIO
• February 11, 2026
Read more
Built for the bold
Let’s make compliance move at the speed of innovation
AI is changing everything. But in regulated spaces, speed without safety isn’t an option. Ketryx helps the world’s most ambitious teams move fast, with zero lag on compliance, safety, or trust.